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C A S E
R E P O R T
Introduction
Carotid body tumor (CBT) is the most common
paraganglioma of the head and neck. Other para-
ganglioma in the head and neck include jugular,
vagal, nasal, orbital, laryngeal, and tympanic tumors
[1]. Embryologically derived from neural crest cells
of the autonomic nervous system, paragangliomas
are similar to the pheochromocytomas histologically.
But unlike pheochromocytoma, paragangliomas
are mainly nonfunctioning, and only 1–3% of para-
gangliomas are hyperfunctioning [2]. Symptoms and
signs such as palpitations, tremors, tachycardia, and
hypertension may indicate possible endocrine activ-
ity of these tumors [3].
Paragangliomas grow along the parasympathetic
nervous system. CBT is a paraganglioma originating
in the chemoreceptors of the carotid body. High
altitude hypoxia-induced hyperplasia of chemore-
ceptor tissues is assumed to be the cause of CBT.
Color Doppler Sonography of the Neck in a
Patient with Bilateral Carotid Body Tumors
Hsin-Ju Cheng , Chih-Hsun Chu2, Chih-Chen Lu1, Po-Chin Wang 3, Shyh-Jer Lin4, 
Chun-Chin Sun, Mei-Chun Wang, Jenn-Kuen Lee1,5, Ming-Ju Chuang , 
Han-Kai Tsai, Hing-Chung Lam1,6*
Paragangliomas are rare cases. Carotid body tumor (CBT) is the most common paragan-
glioma of the head and neck. Embryologically derived from neural crest cells, paragan-
glioma and pheochromocytoma are similar in histology. But unlike pheochromocytoma,
almost all paragangliomas are nonfunctional. Duplex sonography is increasingly used as
the first noninvasive diagnostic tool for neck mass. However, for more detail of soft tissue
nearby, magnetic resonance imaging (MRI) and computed tomography (CT) with 3D
reconstruction are preferred. Herein we report a patient having bilateral CBT concomi-
tant with bilateral pheochromocytomas. Duplex sonography clearly demonstrates the
tumor and surrounding carotid arteries. Compared with CT, duplex sonography is a more
rapid, convenient, safe, and economic measurement for the first diagnostic step.
KEY WORDS — carotid body tumor, paraganglioma, sonography, ultrasound
■ J Med Ultrasound 2009;17(2):114–119 ■
Received: September 17, 2008 Accepted: November 24, 2008
Division of Endocrinology and Metabolism, Kaohsiung Veterans General Hospital, 1National Yang-Ming
University and 2Tzuhui Institute of Technology, 3Department of Radiology, Kaohsiung Veterans General
Hospital, 4Division of Hematology, Kaohsiung Veterans General Hospital, 5Laboratory of Biochemistry,
Kaohsiung Veterans General Hospital, 6Yuh-Ing Junior College of Health Care & Management.
*Address correspondence to: Prof. Hing-Chung Lam, Division of Endocrinology and Metabolism, Department of
Internal Medicine, Kaohsiung Veterans General Hospital, No. 386, Ta-Chung 1st Road, Kaohsiung, Taiwan.
E-mail: hclam@vghks.gov.tw
The prevalence of CBT at high altitude is ten times
more frequent than that at sea level [1]. The weight
of a combined carotid body at sea level is around
20 mg, and that at high altitude is about 60 mg [4].
The female to male ratio of CBT is around 2:1 at
sea level, but elevated to 8:1 at high altitude [5]. A
lower baseline hemoglobin level accounts for the
higher sensitivity of females to hypoxia. Additionally,
genetic defects contributed to familial paragan-
gliomas have also been proposed [6]. About 10–50%
of paragangliomas are familial type [7] and the ge-
netic defects may involve the oxygen-sensing and
signaling pathway [6]. Furthermore, neovasculariza-
tion due to the hypoxia-activated vascular endothe-
lial growth factor may also be involved in the
pathogenesis of CBT [8]. Contrastingly there are
some conflicts to the stance that low hemoglobin
levels or high altitude are related to hypersensitivity
of a carotid body. Luna-Ortiz et al have shown that
there were no significant differences in the mean
hemoglobin and hematocrit between residents liv-
ing at high altitude or low altitude [9]. Hence they
suggested that ethnicity may play a role.
Though angiography was commonly performed
in the diagnosis of a carotid body tumor in the past
[3], the rapidity, convenience, and safety of color
duplex sonography means it is performed more
frequently as the first diagnostic tool. Some papers
have mentioned sonography in the diagnosis of
carotid body tumors, but few have shown the sono-
graphic images [10,11]. In this report we submit
images of carotid body tumors using 2D imaging,
duplex sonography, and multidetector computed
tomography (CT) with 3D reconstruction.
Case Report
A 36-year-old man was referred to our institution
with a bilateral palpable neck mass and rapid body
weight loss. He had found bilateral neck mass over
submandibular area 5 years beforehand. However,
he felt two neck masses grow rapidly with a body
weight loss of about 5 kg in the last 2 months. He
visited a local hospital where a series of imaging
studies including CT and MRI of the neck and CT
of the abdomen were performed. However only
tumors in bilateral carotid spaces as well as over
bilateral adrenal glands were disclosed. Biopsy of
the left-sided neck mass was performed which 
revealed a pheochromocytoma-like tumor. The level
of urine vanillylmandelic acid (VMA) of this patient
in 24 hours was 22.13 mg/day. He was referred to
our institution for further management.
Physical examination disclosed a slim build with
a low body mass index (BMI) (height 178cm, weight
51.2 kg, BMI 16.12 kg/m2), blood pressure of 115/
82 mmHg, a heart rate of 100 beats per minute, a
respiratory rate of 18/min, and a body temperature
of 36.1°C. A bilateral pulsatile and painless mass of
about 3 ×2 cm2 in size was noted below the angle
of the mandible. Otherwise, there were no significant
findings and his blood pressure remained normal
during hospitalization. Endocrine tests including
serum thyroid hormones, parathyroid hormones,
prolactin, cortisol, adrenocorticotropin (ACTH), and
aldosterone levels were unremarkable. Neck sonog-
raphy (Figs. 1 and 2), neck to abdominal CT (Fig. 3),
and whole abdominal MRI (not shown) revealed
only the presence of bilateral CBT concomitant bi-
lateral adrenal tumors. An otolaryngologist did not
suggest surgical management of his carotid body
tumors due to a high risk of neurological compli-
cations. The patient was referred to a urologist to
consider adrenalectomy. Six months after he was
discharged from our hospital, he visited our clinic
again. There was no further body weight loss dur-
ing the 6 months and he had still not decided to
receive adrenalectomy.
Discussion
Although some suggest that CBT is present more in
people living at high altitude and in females with
relatively low hemoglobin, our patient was a previ-
ously healthy man who lived at sea level, and his
hemoglobin was 13.2 g/dL on admission.
A painless cervical mass may be the initial pres-
entation of CBT [3,5,9]. The duration of symptoms
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may range from 1 to 5 years prior to the diagnosis
due to the slow progression of the tumor [5,7]. This
patient noticed bilateral painless cervical masses 5
years beforehand but had paid no attention to it due
to a lack of initial symptoms. Only 3% of paragan-
glioma may transform into malignancy [12]. There
are no histological characteristics for distinguishing
malignant changes in paraganglioma. Malignancy is
defined as paraganglioma with distant metastases.
The most reported sites of metastases include the
liver, bone, kidney, lung, breast, pancreas, retroperi-
toneum and thyroid [13,14]. Systemic symptoms
like malaise, weight loss or weakness may suggest
metastatic disease [3].
Although the patient had a weight loss of about
5 kg in 2 months, he did not report any other dis-
comfort. He visited our clinic again 6 months after
discharge and we noticed that there was no further
body weight loss during that period. Image surveys
and laboratory examinations during hospitaliza-
tion favored bilateral CBT and bilateral pheochro-
mocytomas without significant metastasis.
Angiography was previously the preferred meth-
od for the diagnosis of carotid body tumors [3]. As
technology progressed, noninvasive procedures like
MRI and CT offered 3D reconstruction and thus
provided more information of soft nearby tissue
[10,15]. Nevertheless, color duplex sonography is
CBT
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Fig. 1. Neck sonography of the right-sided CBT. (A) Right-sided neck mass, transverse view. CBT was partially surrounded by inter-
nal carotid artery (thick arrow) and external carotid artery (thin arrow), compatible with Shamblin class II tumor. (B) Right-sided
neck mass, transverse view with Doppler scan. Blue confirmed these vessels were arteries, an internal (thick arrow) and an external
(thin arrow) carotid artery. Red confirmed the internal jugular vein (double arrow). (C) Right-sided neck mass, longitudinal view.
CBT presented as a mass lesion surrounded by the internal (thick arrow) and external (thin arrow) carotid artery. (D) Right-sided
neck mass, longitudinal view with Doppler scan.
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Fig. 2. Neck sonography of the left-sided carotid body tumor (CBT) scanning from upper to lower portion. (A) Left-sided neck
mass, transverse view, 2D image. CBT between the internal (thick arrow) and external (thin arrow) carotid artery. (B) The internal
and external artery was partially embedded in the CBT, which is compatible with a Shamblin class II tumor. (C) The internal and
external arteries became closer together. (D) The carotid artery bifurcation site.
A B
Fig. 3. Neck CT, 3D reconstruction, oblique sagittal view. (A) Shows the patient’s left CBT, surrounded by an internal and 
external carotid artery. (B) The right CBT.
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still recommended as the first diagnostic step by
some authors [10], and a high diagnostic rate of
around 90% has been proposed by Jansen et al [16]
and Kapfer et al [17]. This is due to the fact that
hypervascularity has been considered a specific crite-
rion for diagnosing a CBT by color duplex sonogra-
phy [18] and hence color Doppler studies are helpful
differential tools in patients with neck lesions that
are difficult to diagnose. Nevertheless, MRI or CT
with 3D reconstruction are still necessary to provide
more information on soft nearby tissue for further
surgical planning.
Treatment choices include surgical resection,
radiation, stereotactic radiosurgery, embolization,
131I-MIBG (metaiodobenzylguanidine) and combi-
nation therapy. Surgical management is the first
choice if the tumor is resectable. The therapeutic
goal of CBT is complete surgical resection of the
tumor with preservation of adjacent neurovascular
structures. Incomplete excision is associated with a
significant local recurrence rate [3]. However, the
size, extension, and localization of the tumor all
influence the possibility of tumor resection and
acceptable morbidity. Shamblin et al proposed a
three-stage classification in 1971 to grade difficulty
of resection in CBT [19]. Class I tumors are defined
as localized and easily resected tumors. Class II
tumors are those partially surrounding the blood
vessels. Class III tumors are those completely en-
cased the carotids. Most cases are class II or class III
tumors when diagnosed [3,9,20] and the morbidity
related to the surgical resection increases for these
class II and class III tumors. In order to avoid neu-
rological deficits, early surgical management for
class III tumors is recommended by Luna-Ortiz et al
[9]. However, because of the high morbidity rate,
some authors have not suggested surgical treatment
for those over 60 years of age unless malignancy is
suspected [21]. Our case had Shamblin class II CBT
tumors  on both sides of the neck. We consulted an
otolaryngologist, but surgical management was
not considered due to the high risk of neurological
complications.
The use of radiotherapy is still controversial 
for CBT management. For unresectable tumors,
radiotherapy with fractionated doses of 1.8–
2.0 Gy/day (total dose 45 Gy) may be considered
for local control [22–24]. As well as the ablation of
local tumor, radiotherapy could also be performed
for distant metastases with good symptom control
[13]. Recently, stereotactic radiosurgery which al-
lows cellular damage within a sharply defined
treatment volume has been employed to stabilize
tumor growth [25]. 131I-MIBG, either used alone or
in combination therapy for metastatic paragan-
gliomas, has been reported to result in clinical im-
provement and complete remission, respectively
[26,27]. Finally, due to the rich vascular nature of
these tumors, preoperative conventional endovas-
cular transarterial embolization [28] and direct
puncture embolization with cyanoacrylate glue or
ethanol [29,30] have been described as useful
adjuvants prior to surgery.
How long should we leave it before we follow up
imaging of a patient with CBT ? René van den Berg
suggested a follow-up interval of approximately 2
years, or even more in stable paraganglioma [13].
Of course, this would depend on changes in the clin-
ical situation of the patient. In conclusion, CBT are
rare tumors of the head and neck and color duplex
sonography can be used as the first-line diagnostic
tool for the detection of CBT.
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